#United States #Pittsburgh #dietary supplements #GLP-1 #GNC

GNC's New Approach to Supporting GLP-1 Consumers

GNC, a premier name in health and wellness, has introduced a significant peer-reviewed journal article entitled, "Dietary Supplement Considerations During Glucagon-like Peptide-1 Receptor Agonist Treatment A Narrative Review," published in Obesity Pillars. This publication is a landmark contribution as it underscores GNC's commitment to providing science-based solutions aimed at individuals utilizing GLP-1 therapies for weight management.

Weight loss medications like Ozempic and Wegovy have gained popularity, prompting a need for thorough guidance on the use of dietary supplements alongside these treatments. In the words of Dr. Brittany Johnson, the lead author, "Patients are increasingly turning to weight loss medications, yet little peer-reviewed guidance exists on how to integrate dietary supplements alongside GLP-1 treatment with diet and exercise." This review is particularly valuable as it bridges this information gap between existing dietary support and GLP-1 medication users.

Key Findings from the Article

This new publication provides vital insights into how dietary supplements can complement GLP-1 therapies for enhanced muscle health, nutrition, and overall well-being. Below are some noteworthy findings:

1. Multivitamins & Vitamin D: These supplements can help address common nutrient gaps, improving the overall status of essential nutrients in users.
2. Omega-3 Fatty Acids: Recognized for their numerous benefits, omega-3s support muscle quality and enhance heart health.
3. Protein, Creatine, HMB: Fundamental in preserving lean body mass and strength, particularly during periods of weight loss.
4. Antioxidants: Nutrients such as curcumin, polyphenols, and CoQ10 are highlighted for their abilities to combat oxidative stress and modulate the body’s inflammatory responses.
5. Fiber & Probiotics: Important for improving bowel regularity and alleviating gastrointestinal side effects often associated with weight loss medications.
6. Thermogenics: Ingredients like caffeine and green tea are noted for their potential to increase energy expenditure, thus aiding in weight management efforts.

The data provided in the article serves as a practical toolkit for clinicians in supporting their patients effectively while enhancing consumer knowledge on supplement use during GLP-1 treatment.

Leading the Industry in Nutritional Support

This latest publication reinforces GNC's standing as a leader in health and wellness. The paper builds on GNC's increasing portfolio of research initiatives, including a pioneering study on nutrient intake among GLP-1 therapy users. The company is currently conducting a follow-up clinical trial that examines nutritional habits, health outcomes, and body composition as they relate to GLP-1 treatments.

Rachel Kreider, GNC's Vice President of Product Innovation and Science, states, "Our research directly informs how we design products and build our GLP-1-focused portfolio." By understanding the unique needs of the burgeoning population exploring GLP-1 therapies, GNC aims to deliver tailored nutritional solutions deeply rooted in scientific research.

GNC's Commitment to Ongoing GLP-1 Support

This publication signifies a crucial development in GNC's ongoing initiative aimed at supporting individuals using GLP-1 medications. By investing consistently in clinical research and establishing academic partnerships, GNC continues to pioneer evidence-based product innovation focused on personalized wellness solutions.

About GNC

With a reputation as a global leader in health and wellness, GNC provides science-based products designed to enhance consumers' health. The company's vast portfolio features products primarily manufactured in the U.S. using globally sourced components, distributed through numerous retail channels. GNC is dedicated to innovation and maintains a robust distribution framework to ensure its products reach consumers around the globe. For more details, visit www.gnc.com.